InvestorsHub Logo

sokol

05/31/20 10:35 AM

#253040 RE: Investor2014 #253034

I think that is the key point to look for right there “... all the trials have a set of objective biomarkers that are subject to pre-specified analysis. This is important because if it can be shown that the group patients in each those trials that did best also correspond to those with the hypothesised biomarkers for response to A2-73 Anavex will likely be able to show convincing statistical significance in those subgroups.” Quoting Investor.